The IL-1β system in epilepsy-associated malformations of cortical development

[1]  A. Vezzani,et al.  Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system , 2006, Neuroscience.

[2]  A. Vezzani,et al.  Inactivation of Caspase‐1 in Rodent Brain: A Novel Anticonvulsive Strategy , 2006, Epilepsia.

[3]  E. Aronica,et al.  Evidence of activated microglia in focal cortical dysplasia , 2006, Journal of Neuroimmunology.

[4]  S. Barger,et al.  Journal of Neuroinflammation Interleukin-1 Mediates Alzheimer and Lewy Body Pathologies , 2022 .

[5]  L. Colom.  Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease , 2006, Journal of neurochemistry.

[6]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[7]  E. Aronica,et al.  Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1β-stimulated release of IL-6 in cultured human astrocytes , 2005, Neuroscience.

[8]  R. Kuzniecky,et al.  A developmental and genetic classification for malformations of cortical development , 2005, Neurology.

[9]  Q. Pittman,et al.  Causal Links between Brain Cytokines and Experimental Febrile Convulsions in the Rat , 2005, Epilepsia.

[10]  A. Vezzani,et al.  Brain Inflammation in Epilepsy: Experimental and Clinical Evidence , 2005, Epilepsia.

[11]  C. Elger,et al.  Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions , 2005, Acta Neuropathologica.

[12]  N. Rothwell,et al.  Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.

[13]  F. Poulsen,et al.  Modulator Effects of Interleukin-1β and Tumor Necrosis Factor-α on AMPA-Induced Excitotoxicity in Mouse Organotypic Hippocampal Slice Cultures , 2005, The Journal of Neuroscience.

[14]  C. Cepeda,et al.  Are Cytomegalic Neurons and Balloon Cells Generators of Epileptic Activity in Pediatric Cortical Dysplasia? , 2005, Epilepsia.

[15]  J. González-Martínez,et al.  The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia , 2005, Brain Research.

[16]  M. Menéndez.  Down syndrome, Alzheimer's disease and seizures , 2005, Brain and Development.

[17]  P. V. van Rijen,et al.  Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy , 2005, Neuropathology and applied neurobiology.

[18]  E. Aronica,et al.  Interleukin-1β down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes , 2005, Journal of Neuroimmunology.

[19]  C. Cepeda,et al.  Pediatric Cortical Dysplasia: Correlations between Neuroimaging, Electrophysiology and Location of Cytomegalic Neurons and Balloon Cells and Glutamate/GABA Synaptic Circuits , 2005, Developmental Neuroscience.

[20]  S. Barger,et al.  S100B‐induced microglial and neuronal IL‐1 expression is mediated by cell type‐specific transcription factors , 2005, Journal of neurochemistry.

[21]  T. Baram,et al.  Interleukin‐1β contributes to the generation of experimental febrile seizures , 2005, Annals of neurology.

[22]  S. Berkovic,et al.  Genetic Association Studies in Epilepsy: “The Truth Is Out There” , 2004, Epilepsia.

[23]  N. Rothwell,et al.  CNS injury: the role of the cytokine IL-1. , 2004, Veterinary journal.

[24]  M. Thom.  Recent advances in the neuropathology of focal lesions in epilepsy , 2004, Expert review of neurotherapeutics.

[25]  E. Aronica,et al.  Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development , 2004, Acta Neuropathologica.

[26]  S. Rivest,et al.  Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy , 2004, Neurobiology of Disease.

[27]  D. Jurič,et al.  Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes , 2004, International Journal of Developmental Neuroscience.

[28]  F. Bethencourt,et al.  Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma , 2004 .

[29]  A. Palmini,et al.  Terminology and classification of the cortical dysplasias , 2004, Neurology.

[30]  T. Babb,et al.  Mechanisms of epileptogenicity in cortical dysplasias , 2004, Neurology.

[31]  M. Nolan,et al.  Recurrent Intractable Seizures in Children With Cortical Dysplasia Adjacent to Dysembryoplastic Neuroepithelial Tumor , 2004 .

[32]  Sanjay M Sisodiya,et al.  Malformations of cortical development: burdens and insights from important causes of human epilepsy , 2004, Lancet Neurology.

[33]  M. Baybis,et al.  Expression of ICAM-1, TNF-α, NFκB, and MAP kinase in tubers of the tuberous sclerosis complex , 2003, Neurobiology of Disease.

[34]  C L Galli,et al.  Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases , 2003, The Journal of Neuroscience.

[35]  M. Avoli,et al.  Epileptiform synchronization in the human dysplastic cortex. , 2003, Epileptic disorders : international epilepsy journal with videotape.

[36]  J. Geurts,et al.  Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. , 2003, Brain : a journal of neurology.

[37]  P. V. van Rijen,et al.  Expression and Cell Distribution of Group I and Group II Metabotropic Glutamate Receptor Subtypes in Taylor‐type Focal Cortical Dysplasia , 2003, Epilepsia.

[38]  E. Hirsch,et al.  The Role of Glial Reaction and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[39]  M. Schultzberg,et al.  Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin‐1 system , 2003, Journal of cellular and molecular medicine.

[40]  G. Sébire,et al.  Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? , 2003, Acta Neuropathologica.

[41]  C. Poser,et al.  Epilepsy and multiple sclerosis , 2003, Epilepsy & Behavior.

[42]  G. Klem,et al.  Epileptogenicity of Focal Malformations Due to Abnormal Cortical Development: Direct Electrocorticographic–Histopathologic Correlations , 2003, Epilepsia.

[43]  C. Steinhäuser,et al.  Glial membrane channels and receptors in epilepsy: impact for generation and spread of seizure activity. , 2002, European journal of pharmacology.

[44]  I. Blümcke,et al.  Gangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies , 2002, Journal of neuropathology and experimental neurology.

[45]  K. Laxer,et al.  Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis , 2002, Journal of Neuroimmunology.

[46]  A. Vezzani,et al.  Functional Role of Inflammatory Cytokines and Antiinflammatory Molecules in Seizures and Epileptogenesis , 2002, Epilepsia.

[47]  F. Baas,et al.  Expression and distribution of id helix‐loop‐helix proteins in human astrocytic tumors , 2002, Glia.

[48]  P. Crino,et al.  Neurodevelopmental Disorders as a Cause of Seizures: Neuropathologic, Genetic, and Mechanistic Considerations , 2002, Brain pathology.

[49]  M. Hurme,et al.  Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. , 2002, Pediatric neurology.

[50]  J. Peltola,et al.  Indicators of inflammation after recent tonic–clonic epileptic seizures correlate with plasma interleukin-6 levels , 2002, Seizure.

[51]  Zhi-sheng Liu,et al.  Serum cytokine levels are altered in patients with West syndrome , 2001, Brain and Development.

[52]  R. Mrak,et al.  Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[53]  T. Klockgether,et al.  Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains , 2001, The Journal of Neuroscience.

[54]  D. Anthony,et al.  Interleukin-1β exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic hippocampal slice cultures , 2001, Neuroscience Letters.

[55]  E. Aronica,et al.  Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy , 2001, Neuropathology and applied neurobiology.

[56]  E. Aronica,et al.  Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex , 2001, Acta Neuropathologica.

[57]  P. Crino,et al.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia , 2001, Neurology.

[58]  E. Aronica,et al.  Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor , 2001, Acta Neuropathologica.

[59]  C. Jolicoeur,et al.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis. , 2001, The American journal of pathology.

[60]  G. Sperk,et al.  Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Babb,et al.  Epileptogenicity Correlated with Increased N‐Methyl‐d‐Aspartate Receptor Subunit NR2A/B in Human Focal Cortical Dysplasia , 2000, Epilepsia.

[62]  D. Swaab,et al.  IL-1β immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis , 2000, Journal of Neuroimmunology.

[63]  F. D. da Silva,et al.  Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy , 2000, The European journal of neuroscience.

[64]  S. Garattini,et al.  Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus , 2000, The European journal of neuroscience.

[65]  K. Kanemoto,et al.  Interleukin (IL)‐1β, IL‐1α, and IL‐1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy , 2000 .

[66]  Shuxian Hu,et al.  Cytokine Effects on Glutamate Uptake by Human Astrocytes , 2000, Neuroimmunomodulation.

[67]  C. Plata-salamán,et al.  Kindling modulates the IL-1β system, TNF-α, TGF-β1, and neuropeptide mRNAs in specific brain regions , 2000 .

[68]  S. Malik,et al.  Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. , 2000, The Journal of pharmacology and experimental therapeutics.

[69]  J. Bockaert,et al.  “Inflammatory” Cytokines , 2000, Journal of neurochemistry.

[70]  T. Babb,et al.  Selective Coexpression of NMDAR2A/B and NMDAR1 Subunit Proteins in Dysplastic Neurons of Human Epileptic Cortex , 1999, Experimental Neurology.

[71]  B. Winblad,et al.  Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid , 1999, Neuroscience.

[72]  M. A. Colivicchi,et al.  Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease , 1999, Neuroscience.

[73]  A. Vezzani,et al.  Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures , 1999, The Journal of Neuroscience.

[74]  C. Elger,et al.  The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies , 1999, Acta Neuropathologica.

[75]  H. Lüders,et al.  Histopathological Correlates of Epileptogenicity as Expressed by Electrocorticographic Spiking and Seizure Frequency , 1998, Epilepsia.

[76]  M. Hasegawa,et al.  Expression of lnterleukin-1 β mRNA and Protein in Human Gliomas Assessed by RT-PCR and Immunohistochemistry , 1998, Journal of neuropathology and experimental neurology.

[77]  Meaghan Morris,et al.  The truth is out there! , 2017, Psych-Talk.

[78]  P. Morales,et al.  Interleukin-1β does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro , 1997, Brain Research.

[79]  R. Thomas,et al.  Seizures and epilepsy in the elderly. , 1997, Archives of internal medicine.

[80]  H. Sontheimer,et al.  Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide , 1996, Neuroreport.

[81]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[82]  M. Avoli,et al.  Seizure‐like discharges recorded in human dysplastic neocortex maintained in vitro , 1995, Neurology.

[83]  N. Rothwell,et al.  Cytokines in neurodegeneration and repair , 1995, International Journal of Developmental Neuroscience.

[84]  N. Rothwell,et al.  Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  R. Pacifici,et al.  Cytokine Production in Blood Mononuclear Cells from Epileptic Patients , 1995, Epilepsia.

[86]  Frederick Andermann,et al.  Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results , 1995, Annals of neurology.

[87]  D. Choi,et al.  Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS , 1994, Neuron.

[88]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[89]  M. Gayle,et al.  Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  H. Morris,et al.  Coexistence of Neoplasia and Cortical Dysplasia in Patients Presenting with Seizures , 1993, Epilepsia.

[91]  H. Vinters,et al.  Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue , 1992, Child's Nervous System.

[92]  M. Satoh,et al.  Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain , 1991 .

[93]  H. Yagisawa,et al.  IL1 induces proliferation and IL6 mRNA expression in a human astrocytoma cell line: positive and negative modulation by chorela toxin and cAMP. , 1990, Biochemical and biophysical research communications.

[94]  C. Dinarello,et al.  Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. , 1987, Journal of immunology.

[95]  Timothy A. Pedley,et al.  Epilepsy : a comprehensive textbook , 2008 .

[96]  B. Giometto,et al.  Immune infiltrates and cytokines in gliomas , 2005, Acta Neurochirurgica.

[97]  A. Vezzani,et al.  Functional role of proinflammatory and anti-inflammatory cytokines in seizures. , 2004, Advances in experimental medicine and biology.

[98]  H. Vinters,et al.  Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy , 2004, Acta Neuropathologica.

[99]  Jerome Engel,et al.  Surgical treatment of the epilepsies , 1993 .

[100]  Jerome Engel,et al.  Outcome with respect to epileptic seizures. , 1993 .

[101]  C D Binnie,et al.  Combined use of subdural and intracerebral electrodes in preoperative evaluation of epilepsy. , 1990, Neurosurgery.